Ресинхронизирующая терапия при хронической сердечной недостаточности: диагностические и лечебные подходы

Хроническая сердечная недостаточность (ХСН) остается одной из наиболее важных проблем современной кардиологии. Одним из эффективных методов ее лечения является ресинхронизирующая терапия (РТ). В статье представлен анализ данных литературы об эффективности РТ в улучшении качества жизни, снижении числа госпитализаций и уровня смертности у пациентов с ХСН с выраженной систолической дисфункцией левого желудочка и расширением комплекса QRS, а также рассматриваются ключевые методы оптимизации РТ.

1. Braunwald E. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. The New England Journal of Medicine. 1997;337(19):1360–9. DOI: 10.1056/NEJM199711063371906

2. Фомин И.В., Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Бадин Ю.В., Галявич А.С. и др. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации – данные ЭПОХА–ХСН. Журнал Сердечная Недостаточность. 2006;7(3):112–5.

3. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л., Беленков Ю.Н. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Журнал Сердечная Недостаточность. 2017;18(1):3–40. DOI: 10.18087/rhfj.2017.1.2346

4. Ponikowski PA, Voors AD, Anker S, Bueno H, Cleland JGF, Coats A et al. Рекомендации ESC по диагностике и лечению острой и хронической сердечной недостаточности 2016. Российский кардиологический журнал. 2017;22(1):7–81. DOI: 10.15829/1560-4071-2017-1-7-81

5. Feygina EE, Artemieva MM, Postnikov AB, Tamm NN, Bloshchitsyna MN, Medvedeva NA et al. Detection of NeprilysinDerived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure. Clinical Chemistry. 2019;65(10):1239–47. DOI: 10.1373/clinchem.2019.303438

6. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. Revista Española de Cardiología (English Edition). 2014;67(1):58. DOI: 10.1016/j.rec.2013.11.003

7. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine. 2004;350(21):2140–50. DOI: 10.1056/NEJMoa032423

8. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine. 2005;352(15):1539–49. DOI: 10.1056/NEJMoa050496

9. Khazanie P, Hammill BG, Qualls LG, Fonarow GC, Hammill SC, Heidenreich PA et al. Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure: Analysis of the ICD Registry and ADHERE. Circulation: Heart Failure. 2014;7(6):926–34. DOI: 10.1161/CIRCHEARTFAILURE.113.000838

10. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac Resynchronization in Chronic Heart Failure. New England Journal of Medicine. 2002;346(24):1845–53. DOI: 10.1056/NEJMoa013168

11. Cleland JGF, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L et al. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CAREHF) trial. European Journal of Heart Failure. 2012;14(6):628–34. DOI: 10.1093/eurjhf/hfs055

12. Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK et al. Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2009;119(7):969–77. DOI: 10.1161/CIRCULATIONAHA.108.793273

13. Linde C, Abraham WT, Gold MR, Daubert JC, Tang ASL, Young JB et al. Predictors of short-term clinical response to cardiac resynchronization therapy: Predictors of CRT clinical response. European Journal of Heart Failure. 2017;19(8):1056–63. DOI: 10.1002/ejhf.795

14. Santangeli P, Di Biase L, Pelargonio G, Dello Russo A, Casella M, Bartoletti S et al. Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology. 2011;32(2):125–35. DOI: 10.1007/s10840-011-9584-y

15. Abraham WT. Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure. Circulation. 2004;110(18):2864–8. DOI: 10.1161/01.CIR.0000146336.92331.D1

16. Lozano I, Bocchiardo M, Achtelik M, Gaita F, Trappe H-J, Daoud E et al. Impact of Biventricular Pacing on Mortality in a Randomized Crossover Study of Patients with Heart Failure and Ventricular Arrhythmias. Pacing and Clinical Electrophysiology. 2000;23(11P2):1711–2. DOI: 10.1111/j.1540-8159.2000.tb07001.x

17. Linde C, Abraham WT, Gold MR, St. John Sutton M, Ghio S, Daubert C. Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms. Journal of the American College of Cardiology. 2008;52(23):1834–43. DOI: 10.1016/j.jacc.2008.08.027

18. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine. 2009;361(14):1329–38. DOI: 10.1056/NEJMoa0906431

19. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. New England Journal of Medicine. 2010;363(25):2385–95. DOI: 10.1056/NEJMoa1009540

20. Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP. Cardiac Resynchronization in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 2008;52(15):1239–46. DOI: 10.1016/j.jacc.2008.06.043

21. Wilton SB, Leung AA, Ghali WA, Faris P, Exner DV. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and metaanalysis. Heart Rhythm. 2011;8(7):1088–94. DOI: 10.1016/j.hrthm.2011.02.014

22. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN et al. Cardiac Resynchronization and Death From Progressive Heart Failure: A Meta-analysis of Randomized Controlled Trials. JAMA. 2003;289(6):730–40. DOI: 10.1001/jama.289.6.730

23. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. European Journal of Heart Failure. 2001;3(4):481–9. DOI: 10.1016/S1388-9842(01)00176-3

24. Zhang Q, Zhou Y, Yu C-M. Incidence, definition, diagnosis, and management of the cardiac resynchronization therapy nonresponder. Current Opinion in Cardiology. 2015;30(1):40–9. DOI: 10.1097/HCO.0000000000000140

25. Champagne de Labriolle A. Influence of conduction time intervals on symptoms and exercise tolerance in patients with heart failure with left ventricular systolic dysfunction. Heart. 2005;91(9):1211–2. DOI: 10.1136/hrt.2004.043588

26. Bader H, Garrigue S, Lafitte S, Reuter S, Jaïs P, Haïssaguerre M et al. Intra-left ventricular electromechanical asynchrony. Journal of the American College of Cardiology. 2004;43(2):248–56. DOI: 10.1016/j.jacc.2003.08.038

27. Whinnett ZI, Davies JER, Willson K, Chow AW, Foale RA, Davies DW et al. Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure. EP Europace. 2006;8(5):358–66. DOI: 10.1093/europace/eul017

28. Duncan AM, Lim E, Clague J, Gibson DG, Henein MY. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. European Heart Journal. 2006;27(20):2426–32. DOI: 10.1093/eurheartj/ehl179

29. Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C et al. Characterization of Left Ventricular Activation in Patients With Heart Failure and Left Bundle-Branch Block. Circulation. 2004;109(9):1133–9. DOI: 10.1161/01.CIR.0000118502.91105.F6

30. Fung JW-H. Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart. 2004;90(1):17–9. DOI: 10.1136/heart.90.1.17

31. Blendea D, Singh JP. Lead positioning strategies to enhance response to cardiac resynchronization therapy. Heart Failure Reviews. 2011;16(3):291–303. DOI: 10.1007/s10741-010-9212-4

32. Singh JP, Heist EK, Ruskin JN, Harthorne JW. “Dialing-in” cardiac resynchronization therapy: Overcoming constraints of the coronary venous anatomy. Journal of Interventional Cardiac Electrophysiology. 2007;17(1):51–8. DOI: 10.1007/s10840-006-9050-4

33. Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JWH, Garrigue S et al. Cardiac Resynchronization Therapy: Part 1 - issues before device implantation. Journal of the American College of Cardiology. 2005;46(12):2153–67. DOI: 10.1016/j.jacc.2005.09.019

34. Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JWH, Garrigue S et al. Cardiac resynchronization therapy: Part 2 - issues during and after device implantation and unresolved questions. Journal of the American College of Cardiology. 2005;46(12):2168–82. DOI: 10.1016/j.jacc.2005.09.020

35. Berberian G, Quinn TA, Cabreriza SE, Garofalo CA, Barrios DM, Weinberg AD et al. Load dependence of cardiac output in biventricular pacing: Left ventricular volume overload in pigs. The Journal of Thoracic and Cardiovascular Surgery. 2006;131(3):666–70. DOI: 10.1016/j.jtcvs.2005.09.017

36. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Metaanalysis: Cardiac Resynchronization Therapy for Patients With Less Symptomatic Heart Failure. Annals of Internal Medicine. 2011;154(6):401–12. DOI: 10.7326/0003-4819-154-6-201103150-00313

37. Kashani A, Barold SS. Significance of QRS Complex Duration in Patients With Heart Failure. Journal of the American College of Cardiology. 2005;46(12):2183–92. DOI: 10.1016/j.jacc.2005.01.071

38. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M et al. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. European Journal of Heart Failure. 2009;11(5):480–8. DOI: 10.1093/eurjhf/hfp034

39. Shah RM, Patel D, Molnar J, Ellenbogen KA, Koneru JN. Cardiacresynchronization therapy in patients with systolic heart failure and QRS interval <=130 ms: insights from a meta-analysis. Europace. 2015;17(2):267–73. DOI: 10.1093/europace/euu214

40. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD et al. Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy. Circulation. 2010;121(18):1985–91. DOI: 10.1161/CIRCULATIONAHA.109.910778

41. Auger D, Ducharme A, Harel F, Marcotte F, Thibault B, O’Meara E. Patient assessment for cardiac resynchronization therapy: Past, present and future of imaging techniques. Canadian Journal of Cardiology. 2010;26(1):27–34. DOI: 10.1016/S0828-282X(10)70332-9

42. Chumarnaya T, Trifanova M, Lyubimtseva T, Lebedeva V, Poroshin I, Trukshina M et al. Impact of Interventricular Lead Distance on Cardiac Resynchronization Therapy Outcomes. 2017 Computing in Cardiology Conference. 2017. [Av. at: http://elar.urfu.ru/handle/10995/75110. DOI: 10.22489/CinC.2017.290-106]

43. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J ürgen, Bakker P et al. long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Journal of the American College of Cardiology. 2002;39(12):2026–33. DOI: 10.1016/S0735-1097(02)01895-8

44. Giannuzzi P, Mezzani A, Saner H, Björnstad H, Fioretti P, Mendes M et al. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. European Journal of Cardiovascular Prevention & Rehabilitation. 2003;10(5):319–27. DOI: 10.1097/01.hjr.0000086303.28200.50

45. Petrovic M, Petrovic M, Milasinovic G, Vujisic Tesic B, Trifunovic D, Petrovic O et al. Gauging the response to cardiac resynchronization therapy: The important interplay between predictor variables and definition of a favorable outcome. Echocardiography. 2017;34(3):371–5. DOI: 10.1111/echo.13453

46. Viveiros Monteiro A, Martins Oliveira M, Silva Cunha P, Nogueira da Silva M, Feliciano J, Branco L et al. Time to left ventricular reverse remodeling after cardiac resynchronization therapy: Better late than never. Revista Portuguesa de Cardiologia. 2016;35(3):161–7. DOI: 10.1016/j.repc.2015.11.008

47. Bleeker GB, Schalij MJ, Bax JJ. Importance of left ventricular lead position in cardiac resynchronization therapy. European Heart Journal. 2007;28(10):1182–3. DOI: 10.1093/eurheartj/ehm085

48. Perez AA, University of Miami Miller School of Medicine, Miami, FL, USA, Woo FW, University of Miami Miller School of Medicine, Miami, FL, USA, Tsang DC, University of Miami Miller School of Medicine, Miami, FL, USA et al. Transvenous Lead Extractions: Current Approaches and Future Trends. Arrhythmia & Electrophysiology Review. 2018;7(3):210–7. DOI: 10.15420/aer.2018.33.2

49. Heist EK. Left Ventricular Endocardial Cardiac Resynchronization Therapy Is Here, But Where Should We Place the Lead? JACC: Clinical Electrophysiology. 2018;4(7):869–71. DOI: 10.1016/j.jacep.2018.04.009

50. Singh JP, Houser S, Heist EK, Ruskin JN. The Coronary Venous Anatomy: a segmental approach to aid cardiac resynchronization therapy. Journal of the American College of Cardiology. 2005;46(1):68–74. DOI: 10.1016/j.jacc.2005.04.017

51. Merchant FM, Heist EK, McCarty D, Kumar P, Das S, Blendea D et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm. 2010;7(5):639–44. DOI: 10.1016/j.hrthm.2010.01.035

52. Jackson LR, Piccini JP, Daubert JP, Hurwitz Koweek LM, Atwater BD. Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible. Journal of Interventional Cardiac Electrophysiology. 2015;43(1):5–12. DOI: 10.1007/s10840-015-9984-5

53. Ypenburg C, Van De Veire N, Westenberg JJ, Bleeker GB, Marsan NA, Henneman MM et al. Noninvasive Imaging in Cardiac Resynchronization Therapy-Part 2: Follow-up and Optimization of Settings. Pacing and Clinical Electrophysiology. 2008;31(12):1628–39. DOI: 10.1111/j.1540-8159.2008.01237.x

54. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O’Halloran D, Elsik M et al. Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy: the TARGET study: a randomized, controlled trial. Journal of the American College of Cardiology. 2012;59(17):1509–18. DOI: 10.1016/j.jacc.2011.12.030

55. Auricchio A, Prinzen FW. Update on the pathophysiological basics of cardiac resynchronization therapy. Europace. 2008;10(7):797–800. DOI: 10.1093/europace/eun127

56. Wilton SB, Shibata MA, Sondergaard R, Cowan K, Semeniuk L, Exner DV. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. Journal of Interventional Cardiac Electrophysiology. 2008;23(3):219–27. DOI: 10.1007/s10840-008-9287-1

57. Revishvili AS, Wissner E, Lebedev DS, Lemes C, Deiss S, Metzner A et al. Validation of the mapping accuracy of a novel non-invasive epicardial and endocardial electrophysiology system. Europace. 2015;17(8):1282–8. DOI: 10.1093/europace/euu339

58. Зубарев С.В., Чмелевский М.П., Буданова М.А., Трукшина М.А., Любимцева Т.А., Лебедева В.К. и др. Возможности неинвазивного электрофизиологического картирования у больных с полной блокадой левой ножки пучка Гиса и различными режимами бивентрикулярной электрокардиостимуляции. Кардиология. 2017;57(5):33–7. DOI: 10.18565/cardio.2017.5.33-37

59. Каштанова С.Ю., Миронова Н.А., Гупало Е.М., Гаман С.А., Малкина Т.А., Тарасовский Г.С. и др. Оценка электрической диссинхронии миокарда с помощью неинвазивного активационного картирования и ее роль в достижении успеха проведения сердечной ресинхронизирующей терапии. Кардиология. 2019;59(4S):21–32. DOI: 10.18087/cardio.2613

60. Зубарев С.В., Чмелевский М.П., Буданова М.А., Трукшина М.А., Рыжков А.В., Пахомов А.В. и др. Совершенствование методики поверхностного неинвазивного эпи- и эндокардиального картирования при нарушениях внутрижелудочковой проводимости. Вестник Аритмологии. 2015;80:42–8

61. Oddone D, Solari D, Nangah R, Arena G, Mureddu R, Giorgi D et al. Optimization of coronary sinus lead placement targeted to the longest right-to-left delay in patients undergoing cardiac resynchronization therapy: The Optimal Pacing SITE 2 (OPSITE 2) acute study and protocol. Pacing and Clinical Electrophysiology. 2017;40(12):1350–7. DOI: 10.1111/pace.13212

62. Koç M, Kaypakli O, Gözübüyük G, Yıldıray Şahin D. Coronary sinus lead delay index for optimization of coronary sinus lead placement. Annals of Noninvasive Electrocardiology. 2018;23(1):e12454. DOI: 10.1111/anec.12454

63. Spencer JH, Larson AA, Drake R, Iaizzo PA. A detailed assessment of the human coronary venous system using contrast computed tomography of perfusion-fixed specimens. Heart Rhythm. 2014;11(2):282–8. DOI: 10.1016/j.hrthm.2013.10.038

64. Morgan JM, Biffi M, Gellér L, Leclercq C, Ruffa F, Tung S et al. ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. European Heart Journal. 2016;37(27):2118–27. DOI: 10.1093/eurheartj/ehv723

65. Reddy VY, Miller MA, Neuzil P, Søgaard P, Butter C, Seifert M et al. Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing. Journal of the American College of Cardiology. 2017;69(17):2119–29. DOI: 10.1016/j.jacc.2017.02.059

66. Occhetta E, Bortnik M, Magnani A, Francalacci G, Piccinino C, Plebani L et al. Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation. Journal of the American College of Cardiology. 2006;47(10):1938–45. DOI: 10.1016/j.jacc.2006.01.056

67. Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, Direct His-Bundle Pacing: A Novel Approach to Cardiac Pacing in Patients With Normal His-Purkinje Activation. Circulation. 2000;101(8):869–77. DOI: 10.1161/01.CIR.101.8.869

68. Deshmukh PM, Romanyshyn M. Direct His-Bundle Pacing: Present and Future. Pacing and Clinical Electrophysiology. 2004;27(6 pt 2):862–70. DOI: 10.1111/j.1540-8159.2004.00548.x

69. Arias MA, Pachón M, Puchol A, Jiménez-López J, Rodríguez-Padial L. Acute and mid-term outcomes of transvenous implant of a new left ventricular quadripolar lead versus bipolar leads for cardiac resynchronization therapy: results from a single-center prospective database. Cardiology Journal. 2012;19(5):470–8. PMID: 23042310

70. Mehta PA, Shetty AK, Squirrel M, Bostock J, Rinaldi CA. Elimination of phrenic nerve stimulation occurring during CRT: Follow-up in patients implanted with a novel quadripolar pacing lead. Journal of Interventional Cardiac Electrophysiology. 2012;33(1):43–9. DOI: 10.1007/s10840-011-9598-5